Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,670.00
-100.00 (-1.48%)
At close: Feb 13, 2026

Daehan Nupharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
20,67529,72619,20221,15615,30315,369
Short-Term Investments
1,0008201,8201,494820830
Trading Asset Securities
9,4026,9712,7586,7206,1974,981
Cash & Short-Term Investments
31,07737,51723,78029,37022,31921,180
Cash Growth
-11.25%57.77%-19.03%31.59%5.38%17.26%
Accounts Receivable
33,51934,03735,10832,95026,51026,795
Other Receivables
5,8514,9353,5522,5543,4082,870
Receivables
40,42039,67239,95937,10431,87831,375
Inventory
37,02837,21532,89030,44820,39114,808
Prepaid Expenses
211.4372.8182.753,64353.8588.35
Other Current Assets
409.43877.531,7732,0771,3911,251
Total Current Assets
109,146115,35498,485102,64176,03368,702
Property, Plant & Equipment
125,01185,04254,31346,97846,29438,570
Long-Term Investments
14,51717,87421,42018,04220,5138,402
Other Intangible Assets
1,1531,122563.83336.14423.59369.7
Long-Term Deferred Tax Assets
986.631,1641,418594.4310,32712,443
Other Long-Term Assets
720.56729.93727.64767.444,0524,246
Total Assets
251,534221,285176,927169,359157,643132,733
Accounts Payable
10,42012,56910,23011,6338,1794,825
Accrued Expenses
7,3598,2487,4966,6085,7873,188
Short-Term Debt
43,50839,65535,67220,52315,81226,501
Current Portion of Long-Term Debt
---13,4614,7002,620
Current Portion of Leases
483.65531.14556.37426.7442.09611.65
Current Income Taxes Payable
178.012,2321,988-4,1805,533
Other Current Liabilities
5,9608,6465,8155,9325,9487,840
Total Current Liabilities
67,90971,88161,75858,58445,04951,119
Long-Term Debt
50,29818,831-2,00615,6319,078
Long-Term Leases
323.8409.87369.21226.1335.16384.84
Pension & Post-Retirement Benefits
2,9554,0624,7614,9314,7924,410
Other Long-Term Liabilities
612.71662.14682.91653.179,3718,502
Total Liabilities
122,09895,84667,57166,40075,17873,494
Common Stock
7,1777,1777,1777,1777,1777,177
Additional Paid-In Capital
55,67655,67655,67655,67655,67655,676
Retained Earnings
61,28854,49741,11230,6097,336-7,708
Treasury Stock
-3,075-3,075-3,075-3,075-3,075-3,075
Comprehensive Income & Other
8,36911,1638,46612,57215,3517,168
Shareholders' Equity
129,436125,439109,356102,95982,46559,239
Total Liabilities & Equity
251,534221,285176,927169,359157,643132,733
Total Debt
94,61459,42736,59836,64236,92039,195
Net Cash (Debt)
-63,537-21,910-12,818-7,272-14,601-18,015
Net Cash Per Share
-4526.95-1561.08-913.25-518.12-1040.30-1283.58
Filing Date Shares Outstanding
14.0414.0414.0414.0414.0414.04
Total Common Shares Outstanding
14.0414.0414.0414.0414.0414.04
Working Capital
41,23743,47336,72744,05830,98417,583
Book Value Per Share
9222.168937.397791.507335.725875.574220.71
Tangible Book Value
128,283124,317108,792102,62382,04258,869
Tangible Book Value Per Share
9140.028857.497751.327311.775845.394194.37
Land
13,77613,58913,02113,02112,9388,642
Buildings
43,40843,39140,51832,67632,73416,493
Machinery
33,06631,09530,10726,97425,85922,784
Construction In Progress
70,39629,9481,1432,366179.4513,301
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.